PMID- 24151231 OWN - NLM STAT- MEDLINE DCOM- 20151021 LR - 20151119 IS - 1522-2594 (Electronic) IS - 0740-3194 (Linking) VI - 72 IP - 3 DP - 2014 Sep TI - Navigator artifact reduction in three-dimensional late gadolinium enhancement imaging of the atria. PG - 779-85 LID - 10.1002/mrm.24967 [doi] AB - PURPOSE: Navigator-gated three-dimensional (3D) late gadolinium enhancement (LGE) imaging demonstrates scarring following ablation of atrial fibrillation. An artifact originating from the slice-selective navigator-restore pulse is frequently present in the right pulmonary veins (PVs), obscuring the walls and making quantification of enhancement difficult. We describe a simple sequence modification to greatly reduce or remove this artifact. METHODS: A navigator-gated inversion-prepared gradient echo sequence was modified so that the slice-selective navigator-restore pulse was delayed in time from the nonselective preparation (NAV-restore-delayed). Both NAV-restore-delayed and conventional 3D LGE acquisitions were performed in 11 patients and the results compared. RESULTS: One patient was excluded due to severe respiratory motion artifact in both NAV-restore-delayed and conventional acquisitions. Moderate to severe artifact was present in 9 of the remaining 10 patients using the conventional sequence and was considerably reduced when using the NAV-restore-delayed sequence (ostial PV to blood pool ratio, 1.7 +/- 0.5 versus 1.1 +/- 0.2, respectively [P < 0.0001]; qualitative artifact scores, 2.8 +/- 1.1 versus 1.2 +/- 0.4, respectively [P < 0.001]). While navigator signal-to-noise ratio was reduced with the NAV-restore-delayed sequence, respiratory motion compensation was unaffected. CONCLUSIONS: Shifting the navigator-restore pulse significantly reduces or eliminates navigator artifact. This simple modification improves the quality of 3D LGE imaging and potentially aids late enhancement quantification in the atria. CI - Copyright (c) 2013 Wiley Periodicals, Inc. FAU - Keegan, Jennifer AU - Keegan J AD - Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK. FAU - Drivas, Peter AU - Drivas P FAU - Firmin, David N AU - Firmin DN LA - eng GR - WT093953MA/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131022 PL - United States TA - Magn Reson Med JT - Magnetic resonance in medicine JID - 8505245 RN - 0 (Contrast Media) RN - 0 (Organometallic Compounds) RN - 1BJ477IO2L (gadobutrol) SB - IM MH - Artifacts MH - Contrast Media MH - Echo-Planar Imaging/*methods MH - Heart Atria/*anatomy & histology MH - Humans MH - Image Enhancement/methods MH - Image Processing, Computer-Assisted/methods MH - Imaging, Three-Dimensional/methods MH - Organometallic Compounds MH - Pulmonary Veins/*anatomy & histology MH - Signal-To-Noise Ratio OTO - NOTNLM OT - artifact OT - late gadolinium enhancement imaging OT - navigator OT - pulmonary veins EDAT- 2013/10/24 06:00 MHDA- 2015/10/22 06:00 CRDT- 2013/10/24 06:00 PHST- 2013/06/11 00:00 [received] PHST- 2013/09/04 00:00 [revised] PHST- 2013/09/04 00:00 [accepted] PHST- 2013/10/24 06:00 [entrez] PHST- 2013/10/24 06:00 [pubmed] PHST- 2015/10/22 06:00 [medline] AID - 10.1002/mrm.24967 [doi] PST - ppublish SO - Magn Reson Med. 2014 Sep;72(3):779-85. doi: 10.1002/mrm.24967. Epub 2013 Oct 22.